NCT00001512 2017-07-02Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen VaccinesNational Institutes of Health Clinical Center (CC)Phase 1 Completed42 enrolled